A new RAND report shows nearly 12% of U.S. adults now use GLP-1 drugs like Ozempic and Wegovy, and it’s changing how they shop. Food companies say the biggest shift isn’t in portion sizes but in the ...
Some of the most significant changes include what GLP-1 users eat at restaurants. Technomic data shows that one-third of ...
The Brighterside of News on MSN
GLP-1 drugs like Ozempic and Wegovy are changing the foods Americans buy
The impact of popular U.S. weight-loss drugs like Ozempic and Wegovy (GLP-1 receptor agonists), upon their initial ...
GLP-1 weight-loss drugs have already seen massive success in the US. While they've made some headway into the European market ...
Independent Analysis Examines ColonBroom GLP-1 Booster Ingredient Transparency, Non-Prescription Supplement Category Context, ...
WASHINGTON — US News & World Report named expansion of GLP-1 medications as the top health and nutrition trend for 2026.
By Danny Barrett, Jr. University of Mississippi Medical Center JACKSON – Drugs initially approved for diabetes are now an ...
Everyday Health on MSN
My insurance won’t cover GLP-1 drugs. What now?
Today, the compounded GLP-1 market is in upheaval. The FDA has banned copies of GLP-1 weight loss drugs, and a number of ...
Industry Report Examines What Consumers Are Searching For After Seeing Weight Loss Patch Ads, What These Products Actually ...
Weight Watchers, through its affiliated Weight Watchers Clinic, is a NovoCare ® Recognized Care Provider based on its demonstrated ability to deliver FDA-approved GLP-1 medications alongside expert ...
GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback